Attaining true transparency in drug trials calls for a better solution than excessive redaction. Learn the drawbacks and benefits of the different methods for anonymization in clinical trials. There is potential for strong industry leaders to emerge — so long as they align themselves with best practice guidelines.
The new Merit-based Incentive Payment System (MIPS) is the latest in the shift from volume to value based care. Based on the MACRA final rule, how physicians score in calendar year 2017 will determine payment adjustments on all 2019 claims. It is imperative for organizations to understand whether their MIPS eligible clinicians are prepared. Read more to learn how leveraging Deloitte’s Network InsightTM can help.